No treatment eliminates postural orthostatic tachycardia syndrome permanently, but a combination of lifestyle adjustments and medications can dramatically reduce symptoms for most people who have it. POTS is defined by a sustained jump in heart rate when you stand up, without a corresponding drop in blood pressure, and it disrupts daily life with lightheadedness, fatigue, brain fog, and exercise intolerance.1PubMed. Diagnostic strategies, test accuracy, and misdiagnosis of POTS: a narrative review of diagnostic criteria, tests, and diagnostic delay The reason no single cure exists has a lot to do with the fact that POTS is not one disease but several overlapping problems wearing the same label.
Why “Cure” Is the Wrong Frame
POTS is better understood as a syndrome, a collection of symptoms with multiple possible underlying causes, than as a single disease with a single fix. Research has identified at least three broad subtypes. In the hyperadrenergic form, the body produces too much norepinephrine or fails to clear it properly, leading to excessive fight-or-flight activation. In the neuropathic form, small nerve fibers that help blood vessels tighten on standing are damaged, so blood pools in the legs and abdomen. In the hypovolemic form, overall blood volume is low, often worsened by deconditioning.2PubMed. Pathophysiology and management of postural orthostatic tachycardia syndrome (POTS): A literature review Most people have a mix of these mechanisms rather than a clean single subtype. Treating POTS well means figuring out which combination of problems is driving your symptoms and targeting them individually.
A long-term outcomes survey published in the Journal of the American Heart Association found that POTS is a chronic disorder associated with significant physical disability along with educational, economic, and social consequences. Many patients cycle through multiple specialists before arriving at a diagnosis, and effective management often requires sustained effort over years rather than a quick fix.3PubMed Central. Long-Term Postural Orthostatic Tachycardia Syndrome Outcomes Survey: Educational, Economic, and Social Impact The good news is that the treatments available, while not curative, can substantially shrink the gap between how you feel and how you want to feel.
Salt, Fluids, and the Blood Volume Problem
The simplest intervention is also one of the most effective. Increasing salt and fluid intake expands your blood volume, which directly addresses one of the core mechanisms in POTS. A study in the Journal of the American College of Cardiology measured total blood volume, plasma volume, and red blood cell volume in POTS patients on a low-salt versus high-salt diet. On the low-salt diet, patients had significantly lower blood volumes than expected for their body size. Switching to a high-salt diet reduced that deficit, driven almost entirely by an increase in plasma volume.4PubMed Central. Effect of High Dietary Sodium Intake in Patients with Postural Tachycardia Syndrome
Most POTS specialists recommend consuming somewhere around 8 to 10 grams of sodium per day, which sounds extreme by general health standards but serves a specific physiological purpose in this population. That amount can be hard to reach through food alone, so many people use salt tablets or electrolyte drink mixes to supplement. If you have been told your whole life to limit salt, the shift can feel counterintuitive, but the reasoning is straightforward: your body is not holding on to enough fluid, and salt helps it retain more.
Compression Garments That Actually Help
When you stand up, roughly 500 mL of blood shifts from your chest into your abdomen, with some moving to the legs. People with POTS often have even more pooling in the splanchnic region, the network of blood vessels around the gut, both while standing and at rest.5PubMed Central. Abdominal-only Compression Garments Reduce Orthostatic Tachycardia and Improve Symptoms in Patients With Postural Orthostatic Tachycardia Syndrome This is why knee-high compression stockings, the kind often recommended first, tend to disappoint. The real problem is in the abdomen, not the calves.
Research published in the Canadian Journal of Cardiology found that abdominal-only compression garments reduced the heart rate jump on standing and improved symptoms even without compressing the full lower body. The mechanism is simple: squeezing the abdomen reduces the capacity of those splanchnic blood vessels, pushing more blood back toward the heart.5PubMed Central. Abdominal-only Compression Garments Reduce Orthostatic Tachycardia and Improve Symptoms in Patients With Postural Orthostatic Tachycardia Syndrome A separate study found that splanchnic compression alone did not lower standing heart rate but did prevent the blood pressure drop that beta-blockers can cause, making the two interventions complementary.6PubMed Central. Splanchnic Venous Compression Enhances the Effects of β-Blockade in the Treatment of Postural Tachycardia Syndrome In practical terms, a snug abdominal binder or high-waisted compression shorts may do more for you than the thigh-high stockings that are harder to put on and less comfortable to wear.
Exercise Training, Starting Horizontal
Exercise is consistently one of the most effective long-term interventions for POTS, but it is also the hardest to start. Standing upright triggers the very symptoms you are trying to train away, and pushing too hard early on often causes flares that make people abandon the program altogether. The strategy that works best starts with horizontal exercise: rowing, swimming, or a recumbent bike, where your body stays relatively level and gravity is not pulling blood into your legs and abdomen. As fitness improves over weeks, the duration and intensity increase, and upright activities like walking or jogging can be added gradually.7PubMed Central. Exercise and non-pharmacological treatment of POTS
A study in the Journal of Physiology found that even short-term exercise training improved cardiovascular responses during exertion in POTS patients. Peak oxygen consumption, a standard measure of aerobic fitness, rose by about 11 percent after training, driven by an increase in stroke volume, the amount of blood the heart pumps per beat. Heart rate recovery after exercise also sped up, a sign of improved autonomic function.8PubMed Central. Short-term exercise training improves the cardiovascular response to exercise in the postural orthostatic tachycardia syndrome Supervised training tends to produce better outcomes than going it alone, partly because a trainer can pace you through the early weeks when symptoms make it tempting to quit.
Exercise is not a cure, but it is probably the closest thing to one. Some patients who complete a structured three-month program see enough improvement that they no longer meet the diagnostic criteria for POTS. The catch is that the benefits depend on continued training. Stop exercising for a few weeks and symptoms often creep back, which tells you something about deconditioning’s central role in the syndrome.
Medications for Heart Rate Control
When lifestyle changes are not enough on their own, several medications can help. The most studied option for taming the heart rate spike is low-dose propranolol, a nonselective beta-blocker. A key finding here is that less is more: low-dose propranolol significantly reduced tachycardia and improved symptoms in POTS patients,9PubMed Central. Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more while higher doses of propranolol and the selective beta-blocker metoprolol failed to improve exercise capacity despite lowering heart rate by a similar amount.10PubMed Central. Low-dose propranolol and exercise capacity in postural tachycardia syndrome: A randomized study This is one of those frustrating areas where the intuition “if a little helps, more should help more” turns out to be wrong.
Ivabradine, a drug originally developed for heart failure, has gained traction as an alternative for POTS. It slows the heart rate through a different pathway than beta-blockers, targeting a specific channel in the heart’s pacemaker cells without lowering blood pressure. A randomized trial in patients with hyperadrenergic POTS found that ivabradine significantly reduced heart rate, improved physical and social functioning, and caused no significant side effects like bradycardia or hypotension.11PubMed. Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syndrome In another study, ivabradine cut the heart rate increase on standing from a median of 40 beats per minute down to 15, with a parallel drop in symptom burden scores. The strong correlation between heart rate reduction and symptom improvement suggests the tachycardia itself is not merely a compensatory response but a direct driver of how awful patients feel.12PubMed Central. Heart Rate Lowering With Ivabradine and Burden of Symptoms in Patients With Postural Orthostatic Tachycardia Syndrome A systematic review covering multiple studies concluded that ivabradine appears effective and safe across different POTS subtypes.13Arquivos Brasileiros de Cardiologia. Use of Ivabradine in the Treatment of Patients with Postural Orthostatic Tachycardia Syndrome (POTS): A Systematic Review
Medications for Blood Pressure and Vascular Tone
Heart rate is not the only target. Some POTS patients need help maintaining blood pressure and keeping blood from pooling where it should not. Midodrine works by tightening blood vessels, which improves the body’s ability to push blood back toward the heart when you stand. Fludrocortisone is a synthetic steroid that helps the kidneys retain sodium, expanding blood volume from the inside out. A study comparing the two in patients with symptoms from low blood pressure found that fludrocortisone raised 24-hour systolic blood pressure more effectively and reduced the number of significant blood pressure drops by about 73 percent, compared with about 52 percent for midodrine.14PubMed. Haemodynamic effects of fludrocortisone and midodrine in patients with symptoms due to hypotension
For people with the hyperadrenergic subtype specifically, where the main problem is sympathetic nervous system overdrive, guanfacine has shown targeted results. In a study published in Hypertension, 85 percent of hyperadrenergic POTS patients reported overall improvement on guanfacine, compared with 44 percent of patients who did not have the hyperadrenergic profile. The hyperadrenergic group also saw significant improvements in fatigue, the impact of symptoms on daily activities, and the overall burden of autonomic dysfunction.15PubMed Central. Hyperadrenergic Postural Tachycardia Syndrome. Clinical Biomarkers and Response to Guanfacine This kind of subtype-matched prescribing is the direction the field is heading: rather than one drug for everyone, the goal is to match the treatment to the mechanism.
The Gut Connection
Gastrointestinal symptoms in POTS are so common they deserve their own attention, because they often go unaddressed or get attributed to a separate condition entirely. Nausea, bloating, abdominal pain, and early fullness after eating are frequently reported. There is a widespread assumption that these symptoms mean gastroparesis, where the stomach empties too slowly, but the data tell a more complicated story. Only about 9 to 18 percent of POTS patients with nausea actually have delayed gastric emptying. The majority have normal or even accelerated emptying.16Arquivos Brasileiros de Cardiologia. Gastrointestinal dysfunction in postural tachycardia syndrome: A review of the literature and overview of treatment
The causes of GI trouble in POTS are likely a mix of factors depending on what else is going on. In patients who also have Ehlers-Danlos syndrome, structural differences in the connective tissue of the gut wall may play a role. In neuropathic POTS, the same small-fiber nerve damage that impairs blood vessel control can directly impair gut motility and hormone secretion.17PubMed Central. Gastrointestinal Symptoms in Postural Tachycardia Syndrome: a Systematic Review Practically, this means that if you are being treated for gastroparesis but your gastric emptying study was normal, your doctor may be aiming at the wrong target. Smaller, more frequent meals, staying hydrated, and in some cases medications that address motility rather than assuming a slow stomach can make a real difference.
The Overlap With Ehlers-Danlos and Mast Cell Activation
If you spend time in POTS patient communities, you will encounter frequent references to a “triad” of POTS, hypermobile Ehlers-Danlos syndrome, and mast cell activation syndrome. These three conditions do appear together in some patients, and the overlap has generated a lot of attention. But the evidence for a unified underlying mechanism linking all three remains thin. A review in Clinical Reviews in Allergy and Immunology noted that the perceived association stems largely from overlapping pools of vague, subjective symptoms, which is not the same as showing that the conditions share a cause.18PubMed. The Relationship Between Hypermobile Ehlers-Danlos Syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), and Mast Cell Activation Syndrome (MCAS)
A more recent systematic review found that only one study came close to demonstrating an association between mast cell activation syndrome, POTS, and Ehlers-Danlos syndrome using full diagnostic criteria, while others did not. The authors concluded that further research using strict, validated diagnostic criteria is needed before anyone can say confidently that these conditions are truly linked.19PubMed. Prevalence of mast cell activation disorders and hereditary alpha tryptasemia among patients with postural orthostatic tachycardia syndrome and Ehlers-Danlos syndrome: A systematic review This matters for treatment because if you assume all three conditions are present without rigorous testing, you may end up on medications targeting mast cells when the actual driver of your symptoms is something else entirely.
The Autoimmune Question
One of the more appealing theories about POTS is that an autoimmune mechanism drives the condition, with antibodies targeting the receptors on blood vessels and the heart. This idea gained momentum partly because POTS often begins after an infection, which is a pattern seen in other autoimmune diseases. However, a rigorous study published in Circulation tested autoantibody concentrations against multiple receptor types in POTS patients and healthy controls using standard methodology and found no significant difference. Nearly all patients and all controls tested above the “seropositive” thresholds, and the antibody levels could not reliably distinguish between someone with POTS and someone without.20PubMed Central. Detection of G Protein-Coupled Receptor Autoantibodies in Postural Orthostatic Tachycardia Syndrome Using Standard Methodology
This does not rule out all autoimmune involvement. It does mean the simple version, where a blood test for specific autoantibodies can confirm autoimmune POTS and guide treatment, has not panned out so far. Some patients with severe, treatment-resistant POTS do appear to respond to immunologic therapies like intravenous immunoglobulin, plasmapheresis, or corticosteroids based on case reports and small case series. But these remain experimental, and the field recognizes the need for large, placebo-controlled trials before these can be recommended broadly.21PubMed Central. Immunotherapies for postural orthostatic tachycardia syndrome, other common autonomic disorders, and Long COVID: current state and future direction
Post-COVID POTS
The COVID-19 pandemic brought POTS into much wider awareness, because a significant number of people with long COVID developed symptoms consistent with the syndrome. POTS that emerges after a viral infection is not new; cases have been documented following mononucleosis, influenza, and other infections for decades. But the sheer volume of post-COVID cases accelerated research and brought funding to a field that had been chronically underfunded.
Patients whose POTS began after COVID-19 appear to share the same symptom profile and treatment responses as those whose POTS predated the pandemic, though some molecular-level differences in blood clotting and inflammatory markers have been identified in preliminary research.21PubMed Central. Immunotherapies for postural orthostatic tachycardia syndrome, other common autonomic disorders, and Long COVID: current state and future direction From a practical standpoint, post-COVID POTS is managed with the same toolkit: salt and fluids, graded exercise, compression, and medications as needed. Some clinicians have observed that post-viral POTS in younger patients can improve substantially over one to two years, but this is not guaranteed, and the long-term trajectory varies widely.
POTS in Children and Adolescents
POTS frequently appears during the teenage years, with a peak around puberty. The diagnostic criteria differ slightly for this age group: in children ages 12 to 19, the heart rate increase threshold is 40 beats per minute or more, higher than the 30-beat threshold used for adults. Diagnostic criteria for children under 12 remain undefined.22American Academy of Pediatrics (AAP) / Pediatrics. Pediatric Postural Orthostatic Tachycardia Syndrome: Where We Stand
The overall symptom picture in pediatric POTS resembles the adult version, with orthostatic intolerance, fatigue, and multiple system complaints, but the social consequences are particularly acute. Missing school, dropping out of sports, and being unable to participate in normal activities during a formative developmental period takes a toll that extends beyond the physical symptoms. Many adolescents with POTS face skepticism from teachers and peers who cannot see their illness, and the diagnostic delay documented in adults is just as common, or worse, in younger patients. Treatment follows the same principles: hydration, salt, gradual exercise, and medication when needed. The somewhat encouraging news is that a portion of adolescents see meaningful improvement as they finish puberty and their autonomic nervous system matures, though there is no guarantee this will happen.
Vagus Nerve Stimulation and Emerging Approaches
Beyond the established treatments, a few newer approaches are under investigation. Non-invasive vagus nerve stimulation, where a small device delivers electrical pulses through the skin of the ear or neck, is being studied as a way to rebalance the autonomic nervous system. The rationale is that POTS involves a shift toward too much sympathetic (fight-or-flight) activity relative to parasympathetic (rest-and-digest) tone, and stimulating the vagus nerve may help restore that balance.23PubMed Central. Non-invasive Vagus Nerve Simulation in Postural Orthostatic Tachycardia Syndrome A randomized clinical trial found that noninvasive vagus nerve stimulation did support this idea, with improvements that appeared related to reductions in inflammatory markers and autoantibodies along with better autonomic tone.24PubMed Central. Noninvasive Vagus Nerve Stimulation in Postural Tachycardia Syndrome: A Randomized Clinical Trial These are early-stage results, and vagus nerve stimulation devices are not yet standard care for POTS, but they represent one of the more promising research directions.
The broader trend in POTS treatment research is moving toward precision: identifying which subtype or combination of subtypes a patient has, matching therapies to the dominant mechanism, and layering treatments rather than relying on any single one. The field is still catching up to the size of the patient population, and many of the most commonly used medications for POTS are prescribed off-label, meaning they were approved for other conditions and adopted for POTS based on clinical experience and smaller studies rather than large definitive trials. This is not unusual in medicine, but it does mean that finding the right combination often involves some trial and error guided by an experienced clinician.